SIGN IN SUBSCRIBE

News Update

ST - Service charge and tips are voluntary payments by consumers and cannot be made compulsory or mandatory on food bills by restaurants or hotels: HCST - Collection of service charge is proving to be a double whammy i.e., they are forced to pay service tax and GST on service charge as well: HCST - Collecting a mandatory service charge as matter of default without giving choice to consumer, cannot be contended to be contractually binding in nature: HCST - Even if implied contract is deemed to exist between consumer and restaurants, upon consumer placing order after being informed about service charge, it would be rendered void: HCST - Mandatory levy of service charge by restaurants is against public interest and undermines economic as well as social fabric of consumers as class: HCCus - Expert opinion is not binding on courts; is relevant only when a final decision on any fact is to be made: SCCus - Courts not experts in scientific disciplines, ergo, accept scientific reports; but if expert opinion suffers from ambiguities, shortcomings, lack of clarity or inadequacy, they cannot be wholly relied upon: SCCus - Since Authorities themselves laid down specific parameters for classification of goods, it is incumbent upon them to ensure that necessary facilities are made available for testing of any disputed article on all these parameters: SCST - Commission received from UTI bank towards credit card swiping charges is taxable under 'Business Auxiliary services': CESTATST - Fact that, in appellant's own case, Tribunal had in 2018 passed final order on very same issues implies that department was aware of the facts - Suppression cannot be invoked: CESTATCX - Tribunal ruled in favor of appellant upholding classification of spice mixes under Chapter 9 of Central Excise Tariff Act, rejecting department's attempt to reclassify them under Chapter 21 with a 12.5% excise duty: CESTATCBIC appoints Cousels / Sr Counsels for HC casesST - Activities of maintaining battery-operated vehicles & road trains at Science City are not taxable under any category of positive list, as funds collected are solely for granting entry to visitors, not for providing taxable service: CESTATReciprocal tariffs - Trump says he is open to make trade deals with countries keen to avoid trade warCus - Brand use must indicate a trade connection to deny SSI exemption: CESTATMamta disagrees with forecast of India becoming largest economy by 2060 at Oxford; BJP castigates herST - Activities of grinding, RT upgradation, gouging, & machining on parts used in power plants, constitutes manufacture; assessee can claim exemption under Notfn No. 8/2005-ST - demand raised under Manpower Recruitment & Supply Agency Service is invalid: CESTATBritish law-maker urges UK Govt to say sorry for Jallianwala Bagh pogromIndia, Japan sign loan agreements worth JPY 191.736 billion for six projectsxAI startup buying X Platform for USD 33 billion: MuskI-T- Re-assessment not tenable where based on borrowed satisfaction, rather than being based on any independent investigation or cogent evidence: ITATCanadians boycott US boozeNITI Aayog launches 2nd edition of 'Trade Watch Quarterly'Vance lambasts Denmark for not keep Greenland safe from China and RussiaI-T- Additions u/s 68 are not tenable where based on a generalized investigation report without proving that transactions were manipulated or involved in price rigging: ITATCabinet also approves 2% DA for 66.6 lakh pensioners & 48.7 lakh govt employeesADB-funded SMILE Program to boost India's Logistics EfficiencyI-T- Additions u/s 68 invalid where assessee provides sufficient documentary evidence to establish the identity, creditworthiness, and genuineness of the loan received from spouse: ITATMoS announces Regional BIRAC Centers to accelerate StartUps and biomanufacturingI-T- Partners' Capital Introduced Before LLP Conversion Cannot Be Added Under Section 68 : ITATGovt has put guardrails against misuse of Personal Data: VaishnawI-T- Past Accumulated Income Can Justify Part of an Investment in Property : ITAT
 
Global CEO of Eli Lilly meets MoS for partnership in Insulin and NCD therapies

By TIOL News Service

NEW DELHI, MAR 26, 2025: GLOBAL CEO of Eli Lilly, world's pioneer Insulin manufacturing Company, David Ricks called on Union Minister of State (Independent Charge) for Science and Technology; Earth Sciences and Minister of State for PMO, Department of Atomic Energy, Department of Space, Personnel, Public Grievances and Pensions, Dr. Jitendra Singh to discuss strengthening partnership, with a focus on Insulin and Non-Communicable Disease (NCD) therapies as well as biomanufacturing.

Eli Lilly, a global pharmaceutical giant headquartered in Indianapolis, Indiana and a global pioneer in Insulin production for Diabetes and several other drugs particularly for Cancer etc has a significant presence in India through its subsidiary, Eli Lilly and Company (India) Pvt. Ltd. The company imports and markets medicines for diabetes, gastric cancer, lung cancer, breast cancer, osteoporosis, rheumatoid arthritis, and other critical diseases. Its operations also extend to Nepal, Bangladesh, and Sri Lanka through partnerships with local pharmaceutical firms.

The talks also covered the establishment of a Centre of Excellence for insulin therapies, as well as clinical trials for advanced treatment options.

Dr. Jitendra Singh, himself a renowned Endocrinologist, emphasized on carrying out studies particularly for India, as there is difference in metabolic disorders faced in India and the rest part of the world. He stressed that food habits and phenotype are different thus central obesity and visceral obesity is quite prevalent.

With diabetes being a major health concern in India, discussions on expanding insulin production and accessibility hold immense significance. Dr. Jitendra Singh, who has been vocal about leveraging biotechnology for affordable healthcare solutions, welcomed the dialogue, emphasizing India's growing capabilities in pharmaceuticals and clinical research. The conversation aligns with the government's broader push for self-reliance in drug manufacturing and innovation in life sciences.

Referring to India's push for affordable healthcare for all and the importance of generic medicine, Dr. Jitendra Singh said "Both Generic Medicine and advancement in specialized medicine can co-exist in India".

Eli Lilly's engagement aligns with the government's broader vision of achieving self-reliance in drug manufacturing and advancing innovation in life sciences. Dr. Jitendra Singh has emphasized that bio-manufacturing plays a crucial role in India's Atmanirbhar Bharat initiative by reducing import dependence and ensuring wider access to cutting-edge therapies. He has pointed out that India's robust pharmaceutical industry, evolving biotech ecosystem, and highly skilled scientific workforce position the country as a potential global leader in bio-manufacturing. The Minister has also highlighted the importance of government-industry collaboration in accelerating research, streamlining regulatory processes, and driving innovation, particularly in insulin production and treatments for non-communicable diseases.

Eli Lilly's engagement with India comes at a time when the country is focusing on bolstering its pharmaceutical industry, not just for domestic needs but also as a global supplier. The potential establishment of a Centre of Excellence could serve as a critical step in making insulin therapies more accessible, reinforcing India's role in combating lifestyle diseases.

The meeting underscores the increasing collaboration between global pharmaceutical firms and the Indian government, with a shared vision of enhancing healthcare accessibility and advancing research in non-communicable diseases.


POST YOUR COMMENTS
   

TIOL Tube Latest

TIOL Tube
Technical Session 1: Decoding New Income Tax Bill 2025

TOP NEWS


VISION 360





Technical Session 2 - Retrospective Taxation - Surge in GST Litigation - Possible Remedies.


Technical Session 3 : Sustainability - An Economic Imperative.

TII LATEST

TIOLCORPLAWS LATEST